Enpicom Expanded ImmunoGenomics Platform

Enpicom has finalized and launched an expanded version of its ImmunoGenomix platform, which it said will support discovery and development of novel immunotherapies, patient stratification for, and treatment monitoring of immunotherapies. The platform now also accepts B cell receptor as well as T cell receptor sequencing data.